EN | TR
E-ISSN: 2602-2974
Cedecea Davisae Bacteraemia after Tocilizumab Usage for Coronavirus Disease-2019 Treatment
PDF
Cite
Share
Request
Case Report
VOLUME: 19 ISSUE: 3
P: 148-151
September 2021

Cedecea Davisae Bacteraemia after Tocilizumab Usage for Coronavirus Disease-2019 Treatment

J Turk Soc Intens Care 2021;19(3):148-151
DOI: 10.4274/tybd.galenos.2021.46330
İrem Akın Şen 1
Cem Şen 2
1. Sağlık Bilimleri Üniversitesi, Erzurum Bölge Eğitim ve Araştırma Hastanesi, Yoğun Bakım Kliniği, Erzurum, Türkiye
2. Sağlık Bilimleri Üniversitesi, Erzurum Bölge Eğitim ve Araştırma Hastanesi, Yoğun Bakım Kliniği, Erzurum, Türkiye
3. Sağlık Bilimleri Üniversitesi, Erzurum Bölge Eğitim ve Araştırma Hastanesi, Acil Tıp Kliniği, Erzurum, Türkiye
4. Sağlık Bilimleri Üniversitesi, Erzurum Bölge Eğitim ve Araştırma Hastanesi, Acil Tıp Kliniği, Erzurum, Türkiye
No information available.
No information available
Received Date: 05.01.2021
Accepted Date: 11.04.2021
Publish Date: 26.08.2021
PDF
Cite
Share
Request

ABSTRACT

Cedecea davisae (C. davisae) is a Gram-negative, non-sporulating, motile rod-shaped bacterium of the Enterobacteriaceae family. Cedecea are new members of the Enterobacteriaceae family. Because of their inherent resistance to some antibiotics, the clinical response could be unpredictable, making the management of Cedecea infection challenging in immunocompromised patients. They have rarely been reported as causes of invasive infection. Cedecea can cause opportunistic infections in elderly patients. To the best of our knowledge, only 13 cases of C. davisae bacteraemia have been reported in literature. In this article, we report a case of C. davisae bacteraemia developed after the usage of tocilizumab for coronavirus disease-2019 treatment. A brief review of the literature is also presented in this article.

Keywords: COVID-19, tocilizumab, Cedecea davisae, sepsis, bacteraemia

References

1
Peretz A, Simsolo C, Farber E, Roth A, Brodsky D, Nakhoul F. A rare bacteremia caused by Cedecea davisae in patient with chronic renal disease. Am J Case Rep 2013;14:216-8.
2
Ammenouche N, Dupont H, Mammeri H. Characterization of a novel AmpC b-lactamase produced by a carbapenem-resistant Cedecea davisae clinical isolate. Antimicrob Agents Chemother 2014;58:6942-5.
3
Bayır Ö, Yıldırım GA, Saylam G, Yüksel E, Özdek A, Korkmaz MH. Atrophic rhinitis caused by Cedecea davisae with accompanying mucocele. Kulak Burun Bogaz Ihtis Derg 2015;25:249-53.
4
Berkowitz FE, Metchock B. Third generation cephalosporin-resistant gram-negative bacilli in the feces of hospitalized children. Pediatr Infect Dis J 1995;14:97-100.
5
Biswal I, Hussain NA, Grover RK. Cedecea lapagei in a patient with malignancy: Report of a rare case. J Can Res Ther 2015;11:646.
6
Ağca H, Bozkurt M. A pneumonia case caused by cedecea lapagei. J Clin Anal Med 2014;5:147-8.
7
Yetkin G, Ay S, Kayabaş U, Gedik E, Güçlüer N, Calişkan A. Cedecea lapagei’nin neden olduğu bir pnömoni olgusu [A pneumonia case caused by Cedecea lapagei]. Mikrobiyol Bul 2008;42:681-4.
8
Janda JM, Abbott SL. The Enterobacteria. Washington: ASM Press; 2006. Uncommon enterobacterial genera associated with clinical specimens; pp. 357–9. [Google Scholar]
9
Dalamaga M, Pantelaki M, Karmaniolas K, Matekovits A, Daskalopoulou K. Leg ulcer and bacteremia due to Cedecea davisae. Eur J Dermatol 2008;18:204-5.
10
Perkins SR, Beckett TA, Bump CM. Cedecea davisae bacteremia. J Clin Microbiol 1986;24:675-6.
11
Çekin Y, Kızılateş F, Dolu S, Öztoprak N, Çekin AH. The first urinary tract infection caused by Cedecea lapagei: a case report and review of the literature. Gaziantep Med J 2014;20:193-5.
12
Lambiase A, Raia V, Del Pezzo M, Sepe A, Carnovale V, Rossano F. Microbiology of airway disease in a cohort of patients with cystic fibrosis. BMC Infect Dis 2006;6:4.
13
Peretz A, Simsolo C, Farber E, Roth A, Brodsky D, Nakhoul F. A rare bacteremia caused by Cedecea davisae in patient with chronic renal disease. Am J Case Rep 2013;14:216-8.
14
Bae BH, Sureka SB. Cedecea davisae isolated from scrotal abscess. J Urol 1983;130:148-9.
15
Aguilera A, Pascual J, Loza E, Lopez J, Garcia G, Liaño F, et al. Bacteraemia with Cedecea neteri in a patient with systemic lupus erythematosus. Postgrad Med J 1995;71:179-80.
16
Farmer JJ 3rd, Sheth NK, Hudzinski JA, Rose HD, Asbury MF. Bacteremia due to Cedecea neteri sp. nov. J Clin Microbiol 1982;16:775-8.
17
Dalamaga M, Karmaniolas K, Arsenis G, Pantelaki M, Daskalopoulou K, Papadavid E, et al. Cedecea lapagei bacteremia following cement-related chemical burn injury. Burns 2008;34:1205-7.
18
Davis O, Wall BM. “Broom straw peritonitis” secondary to Cedecea lapagei in a liver transplant recipient. Perit Dial Int 2006;26:512-3.
19
Kanakadandi VS, Sarao MS, Cunningham JM. A Rare Case of Cedecea Davisae Bacteremia Presenting as Biliary Sepsis. Cureus 2019;11:e5298.
20
Hassu ÖK, Çelik İ. Cedecea lapagei’nin Neden Olduğu Nadir Bir Bakteremi Olgusu. FLORA 2018;23:88-91.
2024 ©️ Galenos Publishing House